Related Experiment Video
Updated: Dec 12, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
ABCA3 deficiency from birth to adulthood presenting as paediatric interstitial lung disease
Jin-Gun Cho1,2,3, Devesh Thakkar4, Peter Buchanan4
1Ludwig Engel Centre for Respiratory Research Westmead Institute of Medical Research Westmead NSW Australia.
Insights
Mutations in the ATP-binding cassette subfamily A member 3 (ABCA3) gene can cause pediatric interstitial lung disease (ILD). This report details a 39-year case of ABCA3-ILD, showing slow progression but eventual pulmonary complications.
Area of Science:
- Pulmonology
- Genetics
- Pediatric Medicine
Background:
- Paediatric interstitial lung disease (ILD) can stem from mutations in surfactant protein genes (SP-B, SP-C) and the ATP-binding cassette subfamily A member 3 (ABCA3) gene.
- Severe ABCA3 mutations (frameshift, nonsense) often lead to neonatal respiratory failure, while milder mutations (missense, splice site, indels) allow survival into infancy and beyond.
- Adult cases of ABCA3 deficiency are rare, with limited data on long-term clinical courses and no established therapeutic guidelines.
Abstract:
Paediatric disorders of pulmonary surfactant may occur due to mutations involving surfactant proteins B and C, and ATP-binding cassette subfamily A member 3 (ABCA3) genes. Recessive frameshift or nonsense ABCA3 mutations are associated with respiratory failure and neonatal death but milder phenotypes of ABCA3 deficiency due to missense, splice site, and insertion/deletions may result in survival beyond infancy. To date, only one case report describes the clinical course from birth to age 21 years and there are less than 10 adult cases. No guidelines exist for medical therapy due to the rarity of this condition. We describe the clinical course of a patient over 39 years and her younger brother who were both diagnosed at birth with an unspecified paediatric interstitial lung disease (ILD) and were eventually diagnosed with ABCA3 mutation in their adulthood. Our report highlights the minimal progression of the ABCA3-related ILD without long-term medications, but the development of dyspnoea due to progressive pulmonary hypertension and airflow obstruction.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Inborn Errors of Metabolism
Breathing